Vivalyx is a medical technology startup based in Aachen, focused on addressing the critical issue of organ failure. The company aims to enhance the vitality and availability of donor organs through innovative solutions. Currently in the preparation phase for certification and associated studies, Vivalyx is developing its core product, Omnisol, a liquid designed to replace human blood in the organ preservation process. The company fosters a dynamic and motivated work environment, offering flexible working arrangements and opportunities for professional growth within a collaborative team.